114 related articles for article (PubMed ID: 31197822)
1. Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy.
Erlandsson J; Pettersson D; Glimelius B; Holm T; Martling A
Br J Surg; 2019 Aug; 106(9):1248-1256. PubMed ID: 31197822
[TBL] [Abstract][Full Text] [Related]
2. Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial.
Pettersson D; Glimelius B; Iversen H; Johansson H; Holm T; Martling A
Br J Surg; 2013 Jun; 100(7):969-75. PubMed ID: 23553796
[TBL] [Abstract][Full Text] [Related]
3. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer.
Pettersson D; Holm T; Iversen H; Blomqvist L; Glimelius B; Martling A
Br J Surg; 2012 Apr; 99(4):577-83. PubMed ID: 22241246
[TBL] [Abstract][Full Text] [Related]
4. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer.
Pettersson D; Cedermark B; Holm T; Radu C; Påhlman L; Glimelius B; Martling A
Br J Surg; 2010 Apr; 97(4):580-7. PubMed ID: 20155787
[TBL] [Abstract][Full Text] [Related]
5. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A
Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762
[TBL] [Abstract][Full Text] [Related]
6. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy.
Valenti V; Hernandez-Lizoain JL; Baixauli J; Pastor C; Aristu J; Diaz-Gonzalez J; Beunza JJ; Alvarez-Cienfuegos JA
Ann Surg Oncol; 2007 May; 14(5):1744-51. PubMed ID: 17334851
[TBL] [Abstract][Full Text] [Related]
7. Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer.
Hesselager C; Vuong T; Påhlman L; Richard C; Liberman S; Letellier F; Folkesson J
Colorectal Dis; 2013 Jun; 15(6):662-6. PubMed ID: 23461819
[TBL] [Abstract][Full Text] [Related]
8. Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer.
Pettersson D; Lörinc E; Holm T; Iversen H; Cedermark B; Glimelius B; Martling A
Br J Surg; 2015 Jul; 102(8):972-8; discussion 978. PubMed ID: 26095256
[TBL] [Abstract][Full Text] [Related]
9. Relationship between of short-course preoperative radiotherapy and serum albumin level and postoperative complications in rectal cancer surgery.
Trifunović B; Kršić J; Bezmarević M; Grbović D; Zeljković D; Nešković B; Soldatović I; Prelević R; Mirković D
Vojnosanit Pregl; 2015 Aug; 72(8):663-9. PubMed ID: 26495691
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Radiotherapy: A Risk Factor for Short-Term Wound Complications after Radical Resection for Rectal Cancer?
Holubar SD; Brickman RK; Greaves SW; Ivatury SJ
J Am Coll Surg; 2016 Aug; 223(2):291-8. PubMed ID: 27112126
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial.
Erlandsson J; Fuentes S; Radu C; Frödin JE; Johansson H; Brandberg Y; Holm T; Glimelius B; Martling A
BJS Open; 2021 Nov; 5(6):. PubMed ID: 35040942
[TBL] [Abstract][Full Text] [Related]
12. Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial.
Erlandsson J; Lörinc E; Ahlberg M; Pettersson D; Holm T; Glimelius B; Martling A
Radiother Oncol; 2019 Jun; 135():178-186. PubMed ID: 31015165
[TBL] [Abstract][Full Text] [Related]
13. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
[TBL] [Abstract][Full Text] [Related]
14. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer.
Kaytan-Saglam E; Balik E; Saglam S; Akgün Z; Ibis K; Keskin M; Dagoglu N; Kapran Y; Gulluoglu M
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1597-1603. PubMed ID: 28374169
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).
Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R
Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551
[TBL] [Abstract][Full Text] [Related]
16. Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy: A comparison of the short- and long-term outcomes in patients with T3 rectal cancer.
Beppu N; Matsubara N; Noda M; Yamano T; Kakuno A; Doi H; Kamikonya N; Kimura F; Yamanaka N; Yanagi H; Tomita N
Surgery; 2015 Jul; 158(1):225-35. PubMed ID: 25900036
[TBL] [Abstract][Full Text] [Related]
17. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
18. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
[TBL] [Abstract][Full Text] [Related]
19. Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer.
Fokstuen T; Holm T; Glimelius B
Radiother Oncol; 2009 Nov; 93(2):293-7. PubMed ID: 19748694
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.
Sauer R; Fietkau R; Wittekind C; Rödel C; Martus P; Hohenberger W; Tschmelitsch J; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R;
Colorectal Dis; 2003 Sep; 5(5):406-15. PubMed ID: 12925071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
